US Measles Cases Hit 35-Year High With Over 2,500 Infections
The United States has recorded 2,566 measles cases and 38 outbreaks in 2026, marking the highest infection rate since 1991, according to the Centers for Disease Control and Prevention (CDC). This surge, reported on August 14, 2026, follows a decline in childhood vaccination rates and a recent federal executive order altering recommended immunization schedules.
The scale of the current crisis is a direct reversal of the progress made after the U.S. declared measles eradicated in 2000. The current figures represent a second year of record-breaking infections. For comparison, the total number of cases for the entirety of 2025 was 2,289; the U.S. has already surpassed that total with a quarter of the year remaining.
Public health infrastructure is now struggling to contain a virus that spreads with extreme efficiency. Families in high-incidence states are increasingly relying on preventative care and rapid response as the disease spreads across 47 states and territories.
Vaccination Gaps and the 95% Herd Immunity Threshold
The CDC reports that 93% of this year’s cases occurred in unvaccinated individuals. The vulnerability is most acute among the youth, with 67% of infections reported in children and adolescents between the ages of 0 and 19.
To prevent community-wide transmission, a population requires “herd immunity,” which the CDC defines as a vaccination rate of over 95%. Current data shows a steady erosion of this shield. Preschool vaccination rates dropped from 95.2% during the 2019-2020 school cycle to 92.5% in the 2024-2025 cycle.
This dip may seem marginal, but the CDC notes it has left approximately 286,000 students “at risk.” Only ten states currently meet the 95% threshold: Alabama, California, Connecticut, Maine, Maryland, Massachusetts, Mississippi, New York, Rhode Island, and Virginia.
The resulting gaps in immunity create “pockets” of vulnerability where a single imported case can trigger a localized epidemic.
Regional Hotspots and Outbreak Distribution
The geographical distribution of the 2026 surge is uneven, with several states bearing a disproportionate burden of the total case count. South Carolina leads the nation in infections, followed closely by Utah.

| State | Confirmed 2026 Cases |
|---|---|
| South Carolina | 670 |
| Utah | 526 |
| Pennsylvania | 280 |
| Texas | 190 |
| Virginia | 176 |
| Florida | 141 |
| Arizona | 109 |
The CDC defines an “outbreak” as a cluster of at least three related infections. While 38 outbreaks have been recorded so far in 2026, this is lower than the 48 recorded throughout 2025. Despite the higher volume of individual cases, there have been no confirmed measles deaths in the U.S. in 2026, a decrease from the three deaths reported last year.
Executive Policy Shifts and Federal Immunization Changes
The spike in cases coincides with a significant shift in federal health policy. On Monday, August 11, 2026, President Donald Trump signed an executive order that reduces the number of federally recommended childhood vaccinations from 18 down to 11.

This policy, developed alongside Health Secretary Robert F. Kennedy Jr., reclassifies several vaccines. Immunizations for the flu, COVID-19, hepatitis A and B, rotavirus, and meningitis are no longer blanket recommendations for all children. Instead, these are now categorized under “risk criteria” or “shared decision-making” between parents and physicians.
The order also mandates a full review of the federal childhood vaccination calendar. This shift in guidance occurs as the U.S. faces its most significant measles challenge in three and a half decades, creating a tension between individual medical autonomy and collective public health security.
The current trajectory suggests that measles will remain a persistent threat to U.S. stability through the end of the year. With the 95% immunity threshold slipping in the majority of states, the window for containment is closing. The ability of the U.S. to reverse this trend depends on whether local health interventions can offset the reduction in federal recommendations.
The resurgence of a disease once considered eradicated serves as a stark reminder of the fragility of public health.